Duration of Scar Maturation: Retrospective Analyses of 361 Hypertrophic Scars Over 5 Years.


Journal

Advances in skin & wound care
ISSN: 1538-8654
Titre abrégé: Adv Skin Wound Care
Pays: United States
ID NLM: 100911021

Informations de publication

Date de publication:
Jan 2019
Historique:
pubmed: 12 12 2018
medline: 22 6 2019
entrez: 12 12 2018
Statut: ppublish

Résumé

Maturation remains the least understood phase of wound healing; estimates of maturation time are broad and inaccurate. A more precise estimation of maturation time could influence scar therapy and give insight to the wound healing cascade. The objective of this study was to assess the mean time between onset and complete maturation of hypertrophic scars. This retrospective study was performed in an outpatient clinic of the Maastricht University Medical Center exclusively focused on scar treatment; 361 patients with a hypertrophic scar were included between September 2010 and December 2015. Date of onset and date of complete maturation were documented in patients' medical files. Patients were divided into three patient groups: <30 years, 30-55 years, and >55 years. Different scar causes and scar therapies were analyzed in relation to maturation time. These results reveal statistically significant differences (P < .05) in mean maturation time between the <30 (35.76 months) and >55 patients (22.53 months) and between >55 and 30-55 year old patients (34.64 months). Significant differences in mean maturation time were also found between scars treated with pressure therapy (23.20 months) and combination therapy (30.59 months), silicone therapy (35.51 months), injection therapy (46.43 months), and other therapies (41.31 months). No significant differences in maturation time were found relative to scar cause. This study shows that hypertrophic scars take significantly more time to completely maturate than previously believed, and older patients show the fastest healing. Further, scars treated with pressure therapy maturate fastest.

Identifiants

pubmed: 30531549
doi: 10.1097/01.ASW.0000547415.38888.c4
doi:

Types de publication

Journal Article

Langues

eng

Pagination

26-34

Auteurs

Sander Kant (S)

In the Department of Plastic Surgery, Maastricht University Medical Center, the Netherlands, Sander Kant, MD, is a researcher; Eric van den Kerckhove, Prof, is a physiotherapist; Carlo Colla, is orthotist/prosthetist; René van der Hulst, Prof Dr, is plastic surgeon; and Andrzej A. Piatkowski de Grzymala, MD, is plastic surgeon. The authors have disclosed no financial relationships related to this article. Submitted March 30, 2017; accepted in revised form December 19, 2017.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH